BIOTREATMENT
The KBO register records legal situation 012 for BIOTREATMENT (Register: dissolution or liquidation); this is today's state according to the register itself, which carries no start date. The 2018 annual accounts show negative equity (€-43k) and a net result of €-244k.
| Equity | €-43k |
| Net result | €-244k |
| Active | 25 yrs |
| Locations | 1 |
Fragile profile, watch health in particular.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Dissolution or liquidation
The KBO register records that this company is being wound up. A twelve-month bankruptcy probability no longer says anything in that case, so we show no figure.
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Fiscal year | 2018 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | - |
| Net profit | €-244k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €2k |
| Equity | €-43k |
| Debt | €41k |
| of which ≤ 1y | €9k |
| of which > 1y | €31k |
| Working capital | €-7k |
| Employees (FTE) | - |
| 2018 | |
|---|---|
| Current ratio | 0.25 |
| Quick ratio | 0.25 |
| Working capital ratio | -293.7% |
| Solvency | -1949.6% |
| Debt / equity | -0.71 |
| Long-term debt ratio | -0.71 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -10978.9% |
| ROE | 563.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2018 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2k |
| Fixed assets | 21/28 | €0 |
| Formation expenses | 20 | €0 |
| Tangible fixed assets | 22/27 | €0 |
| Financial fixed assets | 28 | €0 |
| Current assets | 29/58 | €2k |
| Amounts receivable within one year | 40/41 | €0 |
| Cash & bank | 54/58 | €2k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2k |
| Equity | 10/15 | €-43k |
| Contributions / capital | 10/11 | €201k |
| Accumulated profits (losses) | 14 | €-244k |
| Provisions & deferred taxes | 16 | €5k |
| Amounts payable | 17/49 | €41k |
| Amounts payable after one year | 17 | €31k |
| Amounts payable within one year | 42/48 | €9k |
| Trade debts payable within one year | 44 | €5k |
| Income statement | ||
| Gross operating margin | 9900 | €-6k |
| Operating result | 9901 | €-11k |
| Financial charges | 65 | €250 |
| Result before taxes | 9903 | €-11k |
| Net result for the period | 9904 | €-11k |
| Result to be appropriated | 9905 | €-11k |
| NACE primary | Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied(72109) |
| Legal form | Public limited company(014) |
| Incorporation | 11-05-2001 |
| Status | Active |
| Postal code | 5032 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92065B0060/00G003 | Wallonia | 2,632 m² | 1 · 1,070 m² | 11.7 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | BIOTREATMENT |